Statistics for A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer

Total visits

views
A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer 0

Total visits per month

views
September 2024 0
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0

File Visits

views
java.util.UUID:014d2393-4db1-49da-8a93-e624e394334b 36
java.util.UUID:b0a4b3a1-6a59-42b5-b6e1-1a6a4d61e66a 18
java.util.UUID:c0ffed7d-7b1a-44e4-80d5-aa188908355d 3
Albany2021Phase-CCBY.pdf 2